Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montréal, Canada
Julie Bruneau, Nelson Arruda, Geng Zang, et al.
Addiction (2018) Vol. 114, Iss. 2, pp. 366-373
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities
Jerel M. Ezell, Suzan M. Walters, Samuel R. Friedman, et al.
Social Science & Medicine (2020) Vol. 268, pp. 113470-113470
Open Access | Times Cited: 84
Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs
Andreea Adelina Artenie, Nanor Minoyan, Brendan Jacka, et al.
Canadian Medical Association Journal (2019) Vol. 191, Iss. 17, pp. E462-E468
Open Access | Times Cited: 30
Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis
Javier Cepeda, Peter Vickerman, Julie Bruneau, et al.
Drug and Alcohol Dependence (2020) Vol. 213, pp. 108135-108135
Open Access | Times Cited: 29
Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model
Mawuena Binka, Naveed Z. Janjua, Jason Grebely, et al.
JAMA Network Open (2020) Vol. 3, Iss. 5, pp. e204192-e204192
Open Access | Times Cited: 27
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Andreea Adelina Artenie, Evan B. Cunningham, Gregory J. Dore, et al.
Clinical Infectious Diseases (2019) Vol. 70, Iss. 11, pp. 2369-2376
Open Access | Times Cited: 28
The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada
Arnaud Godin, Nadine Kronfli, Joseph Cox, et al.
International Journal of Drug Policy (2020) Vol. 88, pp. 102738-102738
Open Access | Times Cited: 23
The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment
Lillian Lourenço, Marian Kelly, Jill Tarasuk, et al.
Canada Communicable Disease Report (2021) Vol. 47, Iss. 12, pp. 505-514
Open Access | Times Cited: 19
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?
Iuliia Makarenko, Andreea Adelina Artenie, Stine Bordier Høj, et al.
International Journal of Drug Policy (2019) Vol. 72, pp. 69-76
Closed Access | Times Cited: 20
Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use
Monica Adams, Catlainn Sionéan, Dita Broz, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. Supplement_5, pp. S401-S409
Open Access | Times Cited: 19
A vulnerability assessment for the HCV infections associated with injection drug use
Nasser Sharareh, Rachel Hess, Scott W. White, et al.
Preventive Medicine (2020) Vol. 134, pp. 106040-106040
Closed Access | Times Cited: 13
Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use
Andreea Adelina Artenie, Emmanuel Fortier, Marie‐Pierre Sylvestre, et al.
International Journal of Drug Policy (2021) Vol. 94, pp. 103205-103205
Closed Access | Times Cited: 11
Gender, sexual orientation identity, and initiation of amphetamine injecting among people who inject drugs: Examination of an expanding drug era in Montreal, Canada, 2011–19
Stine Bordier Høj, Nanor Minoyan, Geng Zang, et al.
Drug and Alcohol Dependence (2023) Vol. 251, pp. 110956-110956
Open Access | Times Cited: 4
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs
Jason Grebely, Alexandra B. Collins, Andreea Adelina Artenie, et al.
International Journal of Drug Policy (2021) Vol. 96, pp. 103469-103469
Closed Access | Times Cited: 9
Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?
Charlotte Lanièce Delaunay, Arnaud Godin, Nadine Kronfli, et al.
International Journal of Drug Policy (2021) Vol. 96, pp. 103343-103343
Closed Access | Times Cited: 8
Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada
Emmanuel Fortier, Stine Bordier Høj, Marie‐Pierre Sylvestre, et al.
International Journal of Drug Policy (2021) Vol. 96, pp. 103439-103439
Closed Access | Times Cited: 8
Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada
Brendan Jacka, Élise Roy, Stine Bordier Høj, et al.
Journal of Viral Hepatitis (2019) Vol. 26, Iss. 12, pp. 1413-1422
Closed Access | Times Cited: 8
Deconstructing the ‘cheque effect’: short‐term changes in injection drug use after receiving income assistance and associated factors
Stine Bordier Høj, Brendan Jacka, Nanor Minoyan, et al.
Addiction (2020) Vol. 116, Iss. 3, pp. 571-582
Closed Access | Times Cited: 6
Social vulnerability in persons with chronic hepatitis C virus infection is associated with a higher risk of prescription opioid use
Adeel A. Butt, Yan Peng, Shashi N. Kapadia, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 5
HCV Medication Receipt Among Individuals With Methamphetamine, Opioid, and Alcohol Use Disorders in Arkansas, 2018–2022: A Long Road Ahead for HCV Elimination in the US South
George Pro, Corey J. Hayes, Jonathan P. Bona, et al.
Journal of Drug Issues (2024)
Closed Access
Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2024 Abstracts

Canadian Liver Journal (2024) Vol. 7, Iss. 1, pp. 72-253
Open Access
Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis
Kyra H. Grantz, Javier Cepeda, Jacquie Astemborski, et al.
Journal of Viral Hepatitis (2024)
Closed Access
HIV and HCV seroincidence, associated factors and drug use in people who inject drugs, SurvUDI network, eastern central Canada, 1995–2020
Karine Blouin, Caty Blanchette, Pascale Leclerc, et al.
International Journal of Drug Policy (2024), pp. 104483-104483
Closed Access
National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status
George Pro, D. Andrew Tompkins, Soraya Azari, et al.
Drug and Alcohol Dependence (2021) Vol. 228, pp. 109092-109092
Closed Access | Times Cited: 2
Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2021 Abstracts.

Canadian Liver Journal (2021) Vol. 4, Iss. 2, pp. 125-254
Open Access | Times Cited: 2
The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada
Arnaud Godin, Nadine Kronfli, Joseph Cox, et al.
medRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access
Page 1 - Next Page

Scroll to top